KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Tax Provisions (2016 - 2025)

AbbVie (ABBV) has disclosed Tax Provisions for 14 consecutive years, with $853.0 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 137.98% to $853.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, up 514.74% year-over-year, with the annual reading at $2.4 billion for FY2025, 514.74% up from the prior year.
  • Tax Provisions for Q4 2025 was $853.0 million at AbbVie, up from $526.0 million in the prior quarter.
  • The five-year high for Tax Provisions was $853.0 million in Q4 2025, with the low at -$2.2 billion in Q4 2024.
  • Average Tax Provisions over 5 years is $329.0 million, with a median of $442.0 million recorded in 2022.
  • The sharpest move saw Tax Provisions surged 756.52% in 2021, then crashed 678.87% in 2024.
  • Over 5 years, Tax Provisions stood at $226.0 million in 2021, then soared by 118.14% to $493.0 million in 2022, then fell by 21.3% to $388.0 million in 2023, then plummeted by 678.87% to -$2.2 billion in 2024, then soared by 137.98% to $853.0 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at $853.0 million, $526.0 million, and $613.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.